Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030
12 Apr 2017
Projections of cancer incidence and burden among the HIV-positive population in the United States through 2030
Results of SUMMIT: a global phII trial of neratinib in HER2/3 mutant solid tumours
Neratinib in HER2 or HER3 mutant solid tumours
Cervical cancer reduction with HPV vaccines
Perspectives on cervical cancer guidelines and vaccination in India
Community engagement and cancer vaccination in India
Translational research and treating resistance
Radiotherapy at Tata Memorial Hospital
Surgical options for gynae-oncology
Arguments against widespread HPV vaccination
Advances in radiotherapy of cervical cancer
Advances in image contouring